日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure.

首创的 MKK4 抑制剂可增强肝脏再生并预防肝衰竭

Zwirner Stefan, Abu Rmilah Anan A, Klotz Sabrina, Pfaffenroth Bent, Kloevekorn Philip, Moschopoulou Athina A, Schuette Svenja, Haag Mathias, Selig Roland, Li Kewei, Zhou Wei, Nelson Erek, Poso Antti, Chen Harvey, Amiot Bruce, Jia Yao, Minshew Anna, Michalak Gregory, Cui Wei, Rist Elke, Longerich Thomas, Jung Birgit, Felgendreff Philipp, Trompak Omelyan, Premsrirut Prem K, Gries Katharina, Muerdter Thomas E, Heinkele Georg, Wuestefeld Torsten, Shapiro David, Weissbach Markus, Koenigsrainer Alfred, Sipos Bence, Ab Eiso, Zacarias Magdalena Ortiz, Theisgen Stephan, Gruenheit Nicole, Biskup Saskia, Schwab Matthias, Albrecht Wolfgang, Laufer Stefan, Nyberg Scott, Zender Lars

MYC determines lineage commitment in KRAS-driven primary liver cancer development

MYC决定KRAS驱动的原发性肝癌发展过程中的谱系定向。

D'Artista, Luana; Moschopoulou, Athina Anastasia; Barozzi, Iros; Craig, Amanda J; Seehawer, Marco; Herrmann, Lea; Minnich, Martina; Kang, Tae-Won; Rist, Elke; Henning, Melanie; Klotz, Sabrina; Heinzmann, Florian; Harbig, Jule; Sipos, Bence; Longerich, Thomas; Eilers, Martin; Dauch, Daniel; Zuber, Johannes; Wang, Xin Wei; Zender, Lars